StockWatch
·
HomeLiveWeekly
Biotechnology: Pharmaceutical Preparations
AGM/EGMJun 12, 2026, 05:21 PM

Aspire Biopharma Adjourns Shareholder Meeting, Reschedules for June 16

AI Summary

Aspire Biopharma Holdings, Inc. announced the adjournment of its shareholder meeting, originally scheduled for June 9, 2026. The meeting was postponed because the company did not achieve the necessary quorum. The company has rescheduled the meeting for June 16, 2026, at 10:00 a.m. EST, with the same virtual access link.

Key Highlights

  • Aspire Biopharma Holdings, Inc. adjourned its shareholder meeting on June 9, 2026.
  • The meeting was adjourned due to not reaching the required quorum.
  • The shareholder meeting has been rescheduled for June 16, 2026, at 10:00 a.m. EST.
  • The link for the adjourned meeting remains www.colonialstock.com/AspireBiopharma2026.
View SEC Filing
ASBP
Biotechnology: Pharmaceutical Preparations
Aspire Biopharma Holdings, Inc.

Price Impact

More from ASBP

Acquisitions1d ago, 10:32 AM

Aspire Biopharma to Acquire Dura Driver Control Systems for $30M Cash

Quarterly ResultMay 15, 4:29 PM

Aspire Biopharma Q1 Net Loss Narrows to $3.22M; Cash Up to $5.86M

SplitMay 14, 4:13 PM

Aspire Biopharma Announces 1-for-30 Reverse Stock Split

More in AGM/EGM

INSW1d ago, 5:21 PM

International Seaways Stockholders Elect Directors, Approve Exec Comp

EVR1d ago, 5:01 PM

Evercore Stockholders Elect Directors, Ratify Auditor, Approve Stock Plan

BRFH1d ago, 4:52 PM

Barfresh Food Group Stockholders Approve Increase in Authorized Shares